Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype.

Abstract excerpt

Pulmonary hypertension associated with interstitial lung disease (PH-ILD) is a progressive condition with limited treatment options and associated with high mortality rates. Inhaled treprostinil (iTre) is the only approved therapy for PH-ILD and has been shown to improve exercise capacity and delay disease progression. However, the conventional outpatient titration schedule requires 8-16 weeks to achieve...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Administration, Inhalation
• Share to Aged
• Share to Antihypertensive Agents